GlassScriptPhysician profile
Alexander Gellman
NPI 1295798775
$340.37
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Srs Medical Systems, INC. | $103.68 | 2019 | |
| Astellas Pharma US INC | $38.34 | 2019 | |
| Janssen Biotech, INC. | $32.02 | 2019 | |
| Photocure INC | $29.13 | 2019 | |
| Antares Pharma, INC. | $25.40 | 2019 | |
| Pfizer INC. | $24.91 | 2019 | |
| Zyla Life Sciences, INC. | $22.59 | 2019 | |
| Abbvie INC. | $13.71 | 2019 | |
| Dendreon Pharmaceuticals LLC | $13.68 | 2019 | |
| Endo Pharmaceuticals INC. | $13.11 | 2019 | |
| Metuchen Pharmaceuticals | $12.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.25 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Gellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.